A multi-modal transformer for cell type-agnostic regulatory predictions
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: Primary Methods/Results describe EpiBERT, a multimodal Transformer pretrained on DNA sequence/chromatin accessibility, then evaluated on held-out cell types for regulatory predictions and variant effects. This is a specific cross-cell-type regulatory-prediction result; computational validation only.
Technology: Primary Methods/Results describe EpiBERT, a multimodal Transformer pretrained on DNA sequence/chromatin accessibility, then evaluated on held-out cell types for regulatory predictions and variant effects. This is a specific cross-cell-type regulatory-prediction result; computational validation only.
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- Primary Methods/Results describe EpiBERT, a multimodal Transformer pretrained on DNA sequence/chromatin accessibility, then evaluated on held-out cell types for regulatory predictions and variant effects. This is a specific cross-cell-type regulatory-prediction result; computational validation only.
- Limitation / still unknown
- The result is limited to the reported dataset, experimental setting and validation in this study; broader generalization and real-world benefit are not established.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC11872434/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.